101 Aufrufe 101 0 Kommentare 0 Kommentare

    Director/PDMR Shareholding

    DXS INTERNATIONAL PLC

    (AQSE: DXSP)

    Notification of Director / PDMR Dealing

    DXS INTERNATIONAL PLC

    The Board of DXS International plc (the “Company” or “DXSP), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems, has received notification that on 6 November 2024 Mr Bob Sutcliffe, the Chairman, purchased a total of 35,000 Ordinary Shares in the Company at a price of 1.3p per share.

    Following this transaction Mr Sutcliffe and his wife’s interest in DXS Ordinary Shares is 1,151,719 Ordinary Shares representing 1.80% of the issued share capital of the Company.

    1

     
    Details of the person discharging managerial responsibilities / person closely associated
    a)

     
    Name

     
    Mr. Robert Sutcliffe

     
    2 Reason for the notification
    a)

     
    Position/status

     
    Chairman
    b)

     
    Initial notification /Amendment

     
    Initial
    3

     
    Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

     
    a)

     
    Name

     

     
    DXS INTERNATIONAL PLC
    b)

     
    LEI

     

     
    2138001R1KEUWTXEVJ44
    4

     
    Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
    a)

     

     

     

     

     

     

     
    Description of the financial instrument, type of instrument Ordinary Shares of 0.33p each
       
    Identification code ISIN GB00B2Q6HZ92
       
    b)

     
    Nature of the transaction

     
    Purchase of shares
    c)

     

     

     

     

     

     
    Price(s) and volume(s)        
        Price(s) Volume(s)  
        1.3p 35,000  
    d)

     

     

     

     

     

     

     

     

     

     

     
    Aggregated information  
       
    - Aggregated volume  
       
    - Price  
       
    e)

     
    Date of the transaction

     

     
    6 November 2024
    f)

     
    Place of the transaction

     

     
    Aquis Stock Exchange

    The Directors of DXS International plc accept responsibility for this announcement.

    Contacts:

    David Immelman
    DXS International plc
    www.dxs-systems.com

     
    01252 719800
    AQSE Corporate Broker and Corporate Advisor
    Hybridan LLP
    Claire Louise Noyce
    020 3764 2341

    Notes to Editors

    About DXS:
    DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively and which should significantly contribute towards the NHS achieving its projected efficiency savings.





    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Director/PDMR Shareholding DXS INTERNATIONAL PLC (AQSE: DXSP) Notification of Director / PDMR Dealing DXS INTERNATIONAL PLC The Board of DXS International plc (the “Company” or “DXSP), the AQSE Growth Market quoted clinical decision support developer and supplier of …